IL6 and systemic sclerosis: Transforming growth factor-β (TGF- β), along with cytokines such as interleukin IL-6 and growth factors including Wnt ligands and platelet-derived growth factor, is implicated as a key factor initiating pathological tissue remodelling in SSc.